The global Non-Steroidal Anti-Inflammatory Drugs Market is expected to reach USD 31.29 billion by 2030, expanding at a CAGR of 5.36% during the forecast period, according to a new report by Grand View Research, Inc. Nonsteroidal anti-inflammatory drugs are drugs that are primarily used to relieve inflammation and pain, as well as to lower elevated body temperature. The high prescription rate of non-steroidal anti-inflammatory drugs (NSAIDs) for relief of symptoms of painful periods, headaches, fever, arthritis, sprains, strains, and other types of chronic pain is expected to drive the market during the forecast period.
The
non-steroidal anti-inflammatory drugs market is expected to witness growth
opportunities owing to factors such as the rising prevalence of targeted
diseases and chronic pain across the globe, coupled with the high prevalence of
these diseases in the geriatric population. Moreover, increasing demand for OTC
NSAIDs and the rising adoption of NSAIDs for headaches, migraines, and
menstrual pain are also expected to boost the growth during the forecast
period.
Moreover,
the increasing prevalence of arthritis and other pain-related disorders is also
expected to support the growth. For instance, the prevalence of osteoarthritis
is higher in the UK, France, and Germany compared to other countries in the
Europe region. The prevalence of arthritis is seen to be lower in people who
are often engaged in physical activities, and its prevalence rises with age. Thus,
the rising prevalence of arthritis is also expected to cater to the growth
during the forecast period.
Key
market players are adopting strategic initiatives such as geographical
expansion and the introduction of combination non-steroidal anti-inflammatory
drugs to increase their market share across the globe. For instance, Alkem Labs
and Dr. Reddy’s Laboratories Ltd have launched their non-steroidal
anti-inflammatory drugs in the U.S. Moreover, increasing approval of OTC drugs
for pain management and other inflammatory diseases is expected to drive growth
during the forecast period. Thus, owing to the various strategies adopted by
key players, the market is likely to boost its growth.
Governments
in various regions are undertaking favorable initiatives to reduce the burden
of migraine, arthritis, and other diseases in their countries. For instance,
the National Institutes of Health has initiated HEAL to accelerate research
activities to improve the management of pain and inflammatory diseases.
Moreover, the Patient-Centered Outcomes Research Institute has undertaken
initiatives to introduce non-opioid treatment options for pain. Such
initiatives are expected to increase growth during the forecast period.
Related Press
Release@ Non-steroidal Anti-inflammatory Drugs Market Report
Non-steroidal Anti-inflammatory Drugs Market Report
Highlights
- In 2021, the
arthritis segment dominated the NSAIDs market owing to the higher prevalence
of arthritis across the globe
- The retail
pharmacy segment held the largest share and is anticipated to maintain its
dominance during the forecast period
- Asia Pacific
region is expected to witness the highest CAGR during the forecast period
owing to factors such as the high prevalence of pain and related
disorders, the high pool of patients, and a rising geriatric population
across the region
- North
America dominated the market in 2021 due to the higher prevalence of
arthritis, the presence of leading market players, and increased research
activities within the region
About Us:
Grand
View Research, Inc. is a U.S. based market research and consulting company,
registered in the State of California and headquartered in San Francisco. The
company provides syndicated research reports, customized research reports, and
consulting services. To help clients make informed business decisions, the
company offers market intelligence studies ensuring relevant and fact-based
research across a range of industries including technology, chemicals,
materials, healthcare and energy.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com
No comments:
Post a Comment